Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Risk Evaluation and Mitigation MeSH Descriptor Data 2025


MeSH Heading
Risk Evaluation and Mitigation
Tree Number(s)
N04.452.871.758
N06.850.505.715.750
Unique ID
D000073938
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D000073938
Scope Note
Strategies required by the US Food and Drug Administration (FDA) Amendments Act of 2007 when a question exists as to whether the benefits of a drug outweigh its risks. These constitute a safety plan with several potential components, including a medication guide, a communication plan, elements to ensure safe use and an implementation system to help guide the prescribers, pharmacists and patients.
Entry Term(s)
ETASU
Elements to Assure Safe Use
NLM Classification #
QV 771
Previous Indexing
Risk Assessment (2009-2017)
Risk Management (2008-2017)
Public MeSH Note
2018
History Note
2018
Date Established
2018/01/01
Date of Entry
2017/07/11
Revision Date
2017/03/01
Risk Evaluation and Mitigation Preferred
Elements to Assure Safe Use Narrower
page delivered in 0.126s